4.55
Cryo Cell International Inc Azioni (CCEL) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2025-05-31 | 2025-02-28 | 2024-11-30 | 2024-08-31 | 2024-05-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
0.50%
7.9288
|
7.9689 | 8.0243 | 8.0667 | 8.0428 |
Cost Of Revenue |
6.45%
1.8565
|
1.9846 | 1.6367 | 2.1258 | 2.0248 |
Gross Profit |
1.47%
6.0723
|
5.9843 | 6.3877 | 5.9409 | 6.0181 |
|
7.07%
4.5797
|
4.9283 | 6.51 | 4.551 | 4.6265 |
Interest Income/Expense |
11.35%
0.5511
|
0.495 | 0.7455 | 0.5335 | 0.3293 |
Benefits Costs and Expenses |
1.10%
7.3537
|
7.4352 | 8.8668 | 6.6869 | 6.5706 |
Costs And Expenses |
6.90%
6.4362
|
6.9129 | 8.1467 | 6.6768 | 6.6513 |
Depreciation and Amortization |
0.91%
0.1901
|
0.1919 | 0.196 | 0.1946 | 0.0598 |
Operating Income/Loss |
41.35%
1.4926
|
1.056 | -0.1223 | 1.3899 | 1.3915 |
Nonoperating Income/Loss |
75.67%
-0.9175
|
-0.5223 | -0.7201 | -0.01 | 0.0807 |
Income/Loss From Continuing Operations Before Tax |
7.75%
0.5751
|
0.5337 | -0.8424 | 1.3799 | 1.4722 |
Income Tax Expense/Benefit |
12.57%
0.2193
|
0.2509 | 1.0192 | 0.3282 | 0.8164 |
Income/Loss From Continuing Operations After Tax |
25.78%
0.3558
|
0.2829 | -1.8616 | 1.0517 | 0.6558 |
|
25.78%
0.3558
|
0.2829 | -1.8616 | 1.0517 | 0.6558 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
0.02%
8.0802
|
8.0822 | -0.0213 | 8.0619 | 8.1175 |
Diluted Average Shares |
0.91%
8.1257
|
8.20 | -0.029 | 8.1735 | 8.2323 |
Basic Earnings Per Share |
33.33%
0.04
|
0.03 | -0.23 | 0.13 | 0.08 |
Diluted Earnings Per Share |
33.33%
0.04
|
0.03 | -0.22 | 0.13 | 0.08 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Capitalizzazione:
|
Volume (24 ore):